SPALLAROSSA, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 1.279
AS - Asia 10
NA - Nord America 4
SA - Sud America 1
Totale 1.294
Nazione #
IT - Italia 1.279
CN - Cina 7
US - Stati Uniti d'America 4
SG - Singapore 3
BR - Brasile 1
Totale 1.294
Città #
Genoa 571
Genova 409
Rapallo 172
Vado Ligure 117
Bordighera 10
Beijing 3
Ashburn 2
Boardman 2
Singapore 2
Cariacica 1
Totale 1.289
Nome #
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 196
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 159
Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. 156
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 95
Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer 94
Patterns of anticoagulation for atrial fibrillation in cancer patients referred to cardio-oncological evaluation 76
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 74
Cancer Patient With Unusual Dyspnea in the COVID-19 Era 74
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy 73
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 72
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 56
Systemic Acute Venous Thromboembolic Disease: Focus on Patients seen by Cardiologists 55
Engineering for Biomedical Sector: A Cross-Industry Approach for the Analysis of Molecular Patterns behind Endothelial Damage Related to Leukemia Therapy 49
Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents? 40
Cardiovascular safety of the tyrosine kinase inhibitor nintedanib 38
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism 35
Totale 1.342
Categoria #
all - tutte 5.931
article - articoli 5.931
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021106 0 0 0 47 0 2 3 15 7 13 9 10
2021/202293 11 0 1 12 1 7 4 25 4 9 1 18
2022/2023201 14 22 2 22 35 26 1 12 29 2 34 2
2023/2024125 11 7 5 21 13 17 6 9 3 5 13 15
2024/2025382 16 17 5 29 31 36 35 83 12 26 41 51
2025/2026201 100 19 36 46 0 0 0 0 0 0 0 0
Totale 1.342